Clinical Trial

Comparison Between Botox and Magnesium Sulfate Effect in Treatment of Myofascial Pain Trigger Points Within the Masseter Muscle

Study acronym: MPS MTrPs BTA
Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated November 12, 2024 (before its estimated February 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this randomized clinical trial is to compare the effectiveness of Botulinum toxin type A, magnesium sulfate and saline injections in treatment of the masseter muscle trigger points, in patients between 16 - 50 years old with myofascial pain with masseter muscle trigger points. The main questions it aims to answer are: * which treatment has longer effect of pain release with the least possible side effects and recurrence rate? * Which treatment has greater impact on improving patient's quality of life? Researchers will compare Botulinum toxin type A, magnesium sulfate to a placebo saline injections in treatment of the masseter muscle trigger points Participants will attend to the clinic 4 times * 1st visit will include taking preoperative records and treatment injection * 2nd visit will be follow up and taking records after 1 month * 3rd visit will be follow up and taking records after 3 months * 4th visit will be follow up and taking records after 6 months
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-04.
Trial Details
NCT Number NCT06676475
Lead Sponsor Misr University for Science and Technology
Conditions Myofacial Pain, Trigger Points, Myofascial
Enrollment 60 participants
Start Date 2024-12-01
Primary Completion 2025-02 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2024-11-12